Keflex (Cephalexin) Dosing for Diabetic Foot Infection with Potential Renal Impairment
For an elderly diabetic woman with a foot infection and potential renal impairment, use cephalexin 500 mg every 12 hours for skin and soft tissue infection, with dose reduction required if creatinine clearance is below 30 mL/min. 1
Standard Dosing for Diabetic Foot Infections
- For skin and soft tissue infections, administer 500 mg every 12 hours orally 1
- The usual adult dose range is 1-4 grams daily in divided doses, with 250 mg every 6 hours being the standard regimen 1
- For more severe infections, larger doses may be needed, but if daily doses exceed 4 grams, parenteral cephalosporins should be considered 1
Critical Consideration: Renal Function Assessment
You must assess renal function before initiating therapy, as this patient has potential renal impairment. 2, 3
- Measure serum creatinine and calculate creatinine clearance (CrCl) immediately 2
- Elderly diabetic patients are at high risk for chronic kidney disease, which significantly affects cephalexin dosing 2, 3
Dose Adjustment for Renal Impairment
If CrCl is less than 30 mL/min, reduce the cephalexin dose proportionally to the reduced renal function 4
- Cephalexin is 70-100% renally excreted within 6-8 hours, making dose adjustment essential in renal impairment 4
- In patients with severe renal failure, the serum half-life increases from 1.1 hours (normal) to 6-18 hours, leading to drug accumulation 5
- For CrCl <30 mL/min, consider reducing frequency to every 24 hours or reducing individual doses by 50% 6, 4
Treatment Duration
Treat for 1-2 weeks for uncomplicated skin and soft tissue diabetic foot infections 7, 8
- Antibiotics should be discontinued once clinical signs and symptoms of infection have resolved, even if the wound has not completely healed 8
- For more extensive infections or those with severe peripheral artery disease, consider extending treatment to 3-4 weeks 9
- If evidence of infection persists after 4 weeks of appropriate therapy, re-evaluate the patient and reconsider diagnostic studies 9
Important Caveats for This Patient Population
First-generation cephalosporins like cephalexin have significant limitations for diabetic foot infections:
- Cephalexin provides coverage primarily against methicillin-sensitive Staphylococcus aureus (MSSA) and streptococci, but has limited activity against many gram-negative organisms commonly found in diabetic foot infections 7, 8
- Diabetic foot infections are typically polymicrobial, often requiring broader spectrum coverage 10
- If the infection is moderate to severe (limb-threatening), cephalexin is inadequate and parenteral broad-spectrum antibiotics are required 7, 8, 10
Monitoring Requirements
- Monitor renal function (serum creatinine) during treatment, especially in elderly patients 2, 3
- Assess clinical response within 48-72 hours; lack of improvement warrants culture-directed therapy adjustment 7
- In patients with renal impairment, antimicrobial activity may persist for 24 hours after dosing, requiring less frequent administration 5
When Cephalexin is Inappropriate
Do not use cephalexin for:
- Moderate or severe diabetic foot infections requiring hospitalization 7, 8
- Infections with suspected Pseudomonas aeruginosa (especially in warm climates or if previously isolated) 9
- Suspected or confirmed osteomyelitis, which requires different antibiotic selection and prolonged therapy 9, 7
- Patients with CrCl <10 mL/min on hemodialysis, where timing with dialysis becomes critical 6